Camber Pharma Launches Generic Baraclude®
Piscataway, NJ, August 21, 2015– Camber Pharmaceuticals announces that it has launched Entecavir Tablets. The drug is the generic version of Baraclude®, which is used to treat chronic Hepatitis B.
Entecavir is available from Camber in .5mg 30 and 90 count bottles and 1mg 30 count bottles.
If you would like more information about this topic, please contact Megan Becker at 732.529.0436 or email at [email protected].
Recent articles
- New to Camber’s Portfolio: Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets
- Camber Pharmaceuticals Honored as Second Merit Finalist at 2026 DIANA Awards
- Camber Launches Nitazoxanide Tablets
- Cisatracurium Besylate Injection, USP Added to Camber’s Portfolio
- Camber Welcomes Summer 2026 Intern Class
- Camber Launches 5 Generics in May






